Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German Merck Aims To Lift Its UK R&D Efforts, Despite Brexit Uncertainty

Executive Summary

Germany's Merck Group plans to bolster its biopharma R&D activities in Britain - despite Brexit - on grounds the UK is too key and dynamic a player in the life sciences sphere not to - and because the conglomerate needs to be there to help ensure its evolution into a top oncology and immuno-oncology innovator.

Advertisement

Related Content

CHMP OK Puts Merck KGaA's Cladribine Pill On EU Home Stretch After Long Trek
2Q Pharma Results Preview: Pfizer, Shire, Merck KGaA, Teva, Novo Nordisk And Allergan
German Merck Identifies Pipeline Stars, Plots Course Through A Dynamic Cancer Space
Merck KGaA: New CEO, New Logo, No Serono
Merck KGaA's Cladribine Revival Smacks Of Desperation
Pfizer sides with Merck KGaA on PD-L1; AZ deal out for good?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC096978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel